CURRENT SCENARIO OF COVID19 OUTBREAK IN ANDHRAPRADESH & TELANGANA
Abstract
The World Health Organization declared the 2019–2020 COVID Emerging coronaviruses are constant global public health threats to society Governments are under increased pressure to stop the outbreak of a global health emergency. In this situation, preparedness, transparency, and sharing of information are crucial. Multiple ongoing clinical trials are conducted for the development of vaccines and antivirals against CoVs. Up to date, there is no specific treatment proven effective against this COVID19. In addition, no vaccine has been licensed by the WHO to prevent MERS-CoV infection thus far. This spillover event is pandemic and a Public Health Emergency of International Concern. Due to its emerging cases day by day there is a need for everyone to act responsibly by taking preventive measures like wearing the masks and avoiding unnecessary outings as possible. There are certain reasons not to get panic regarding a situation like We to know why at it is - we had been identified the virus; We know how to detect-there had many tests to identify; Most cases are mild -about 81% of cases are mild and high recovery rate is seen; Symptoms are mild in young; The virus can be destroyed on the surface; Vaccines are in progress; Many drugs are effective in treating the COVID19. Voluntary reporting of the symptoms helps to prevent the spread of disease. this review details about the origin of the virus, introduction to the anatomical features and pathology, clinical manifestations, its diagnostics, treatment, preventive measures to health workers, and to public.
Downloads
References
2. Neelesh Jain, Animesh choudhury, Jayesh Sharma, et al. A Reiew of Noel Coronavirus Infection (Coronavirus Disease-19). Glob J Transfus Med 2020;5:22.6
3. Lisheng Wang, Yiru Wang, et al. Review of the 2019 novel coronavirus(SARS-COV-2) based on current evidence. https://doi.org/10.1016/j.ijantimicag.2020.105948.
4. Tanu Singhal. A Review of Coronavirus Disease-2019(COVID-19). The Indian Journal of pediatrics (April 2020) 87(4):281-286. https://d0i.org/10.1007/s12098-020-03263-6
5. M.Tobaiqy, M.Qashqary, S.Al.Dahery, et al. Therapeutic management of patients with COVID-19: a systemic review. https://doi.org/10.06/j.infpip.2020.100061
6. Syed Adeel Hassan, Fahad N.Sheikh, et al. Coronavirus(COVID-19): A Review of Clinical Features, Diagnosis and Treatment. Cureus 12(3):e7355.DOI 10.7759/cureus.7355
7. Zhangkai J. Cheng, Jing Shan. 2019 Novel coronavirus:Where we wre and what we know. https://doi.org/10.1007/s15010-020-01401-y
8. Ali Moh Zaki, Sander VAan Boheemen, et al. Isolation of a Novel Coronavirus from a man with Pneumonia in Saudi Arabia. N Eng J Med 2012;367:1814-20. DOI: 10.1056/NEJMoa1211721
9. Varsha Kachroo. Novel Coronavirus (COVID-19) in India: Current Scenario. International Journal of Research and Review (ijrrjournal.com) vol.7; Issue:3; March 2020
10. Pranab Chatterjee, Nazia Nagi, et al. The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. Indian J Med Res 151, February & Mach 2020, pp 147-159.
11. A novel coronavirus outbreak of global health concern. https://doi.org/10.1016/s0140-6736(20)301855-9
12. Koul PA, Dhar R. COVID-9 pandemic in india: A Clarion call for better preparedness. Lung India 2020;37:187-9.
13. Isaac Ghinai, Tristan D McPherson, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-22) in the USA. Lancet 2020;395:1137-44. https://doi.org/10.1016/s0140-6736(20)30607-3
14. Giuseppe Pascarella, Alessandro Strumia, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020; https://doi.org/10.1111/joim.13091
15. Sasmita Poudel Adhikari, Sha Meng, Yu-Ju Wu, et al. Epidemiology,causes,clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. https://doi.org/10.1186/s40249-020-00646-x
16. Ranit Chatterjee, Sukhreet Bajwa, et al. COVID-9 Risk Assessment Tool: Dual application of risk communication and risk governance. Progress in Disaster Science 7(2020) 100109. http://dx.doi.org/10.1016/j.pdisas.2020.100109
17. Renyi Zhang, Yixin Li, et al. Identifying airborne transmission as the dominant route for the spread of COVID-19. www.pnas.org/cgi/doi/10.1073/pnas.2009637117
18. Ahmet Riza Sahin, Aysegul Erdogan, et al. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO 2020;4(1):1-7
19. M.David, Lokeshkumar p, et al. COID-19 (CORONA VIRUS): A Global Emergency outbreak and its implications in India. Int. J. Zool. Appl. Biosci.,5(2), 89-98,2020.
20. M.A.Chilvers, M.McKean, et al. The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur Respir J 2001; 18:965-970.
21. Sarah Dryhurst, Claudia R, et al. Risk perceptions of COVID-19 around the world. Journal of Risk Research. https://doi.org/10.1080/13669877.2020.175893
22. Fan-Yun Lan, Chih-Fu Wei, et al. Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study. PLOS ONE 15(5): e0233588. https://doi.org/10.1371/journal.pone.0233588
23. Kapil Ghosh, Nairita Senguta, et al. Inter-state transmission potential and vulnerabilityof COVID-9. https://dx.doi.org/10.1016/j.pdisas.2020.100114
24. Malizgani Mhango, Mathias Dzobo, et al. COVID-19 Risk factors among health workers: A Rapid Review. https://doi/10.1016/j.shaw.2020.06.001.
25. Jing Yang, Ya Zheng, et al. Prevalence of comorbidities and its effects in patients infected with SARS-COV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases 94(2020) 91-95.
26. Mohammad Madjid, Payam Safai-Naeini,et al. Potential Effects of Coronaviruses on the Cardiovascular System. JAMA Cardiol. doi:10.1001/jamacardio.2020.1286.
27. Thankappan KR. Combating corona irus disease 2019 and comorbidities: The Kerala experienxe for the first 100 days. Int J Non-Common Dis 2020;5:36-42.
28. Naeen Ramesh, et al. Tackling corona virus disease 2019(COVID-19) in workplaces. Indian J Occup Environ Med 2020;24: 16-8.
29. Abhilasha, Prasenjit Mitra, et al. Association of comorbidities with Coronavirus Disease 2019: A Reiew. https://doi.org/10.1055/s-0040-1714159.
30. Julie M. Shabto, Leah Loerinc, et al. Characteristics and outcomes of COID-19 positive patients with diabetes managed as outpatients. https://doi.org/10.1016/j.diabres.2020.108229.
31. Nicholas G. Davies, Petra Kelpac, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. https://doi.org/10.1038/s41591-020-0962-9.
32. Domenico Umberto De Rose, et al. Novel Coronavirus disease (COID-19) in newborns and infants: What we know so far, Italian journal of pediatrics. https://doi.org/0.1186/s13052-020-0820-x.
33. Dipika B Utekar, Shital S Nikam, et al. Trending outbreak of coron virus sars-cov-2: a review. Int J Mol Bio open Access. 2020;5(2):40-44.
34. Saleem H, Rahman J, et al. Coronavirus Disease 2019(COVID-19) in children: Vulnerable or spared? A Systematic Review. DOI: 10.7759/cureus.8207.
35. Ahmad S, Hafeez A, et al. A Review of COVID-19 (Coronavirus Disease-2019) Diagnosis, Treatments and Prevention. EMJO 2020;4(2):116-125.
36. Pooja, Rajan Rana, et al. Preventive measures against initial outbreaks of COVID-19 in India: A review. Biomedical Research 2020; 31(2)
37. Tarek Mahbub Khan. Preventive and Control Measures of COVID-9 Patients: A Review. https://doi.org/10.3329/bjid.7i0.46800.
38. Jeremy Howard, et al. Face masks against COVID-19: An Evidence Review. doi:10.20944/preprints202004.0203.v1.
39. Bourouiba L. et al.Masks and Coronavirus Disease 2019 (COVID-19). JAMA May 26,2020. volume 323, number 20.
40. Susanna Esposito, Nicola Principi, et al. Universal use of face masks for success against COVID-19: evidence and implications for prevention policies. https://doi.org/10.1183/13993003.01260-2020.

.